DateI.; ShingoT.; YoshidaH.; FujiwaraK.; KobayashiK.; OhmotoT.Grafting of encapsulated dopamine-secreting cells in Parkinson's disease: Long-term primate study.Cell Transplant.9: 705–709; 2000.
2.
EnosawaS.; MiyashitaT.; SuzukiS.; LiX-K.; TsunodaM.; AmemiyaH.; YamanakaM.; HiramatsuS.; TanimuraN.; OmasaT.; SugaK.; MatsumuraT.Long-term culture of glutamine synthetase-transfected HepG2 cells in circulatory flow bioreactor for development of a bioartificial liver.Cell Transplant.9: 711–715; 2000.
3.
HaraK.; UchidaK.; FukunagaA.; KuroshimaY.; YamadaM.; KawaseT.Neurite growth capability of rat fetal neuronal cells against matured CNS myelin in vitro.Cell Transplant.9: 717–724; 2000.
4.
HeL.; DonoK.; GotohM.; OkumuraM.; TakedaY.; ShimizuJ.; NaganoH.; NakamoriS.; UmeshitaK.; SakonM.; MondenM.Role of the liver in alloimmune response following inoculation of donor spleen cells.Cell Transplant.9: 725–728; 2000.
5.
KawakamiY.; IwataH.; GuY.; MiyamotoM.; MurakamiY.; YamasakiT.; CuiW.; IkadaY.; ImamuraM.; InoueK.Modified subcutaneous tissue with neovascularization is useful as the site for pancreatic islet transplantation.Cell Transplant.9: 729–732; 2000.
6.
KobayashiN.; MiyazakiM.; FukayaK.; InoueY.; SakaguchiM.; NoguchiH.; MatsumuraT.; WatanabeT.; TotsugawaT.; TanakaN.; NambaM.Treatment of surgically-induced acute liver failure with transplantation of highly differentiated immortalized human hepatocytes.Cell Transplant.9: 733–735; 2000.
7.
KobayashiN.; NoguchiH.; WestermanK. A.; MatsumuraT.; WatanabeT.; TotsugawaT.; FujiwaraT.; LeboulchP.; TanakaN.Efficient Cre/loxP site-specific recombination in a HepG2 human liver cell line.Cell Transplant.9: 737–742; 2000.
8.
KobayashiN.; ItoM.; NakamuraJ.; CaiJ.; HammelJ. M.; FoxI. J.Treatment of carbon tetrachloride and phenobarbital-induced chronic liver failure with intrasplenic hepatocyte transplantation.Cell Transplant.9: 671–673; 2000.
9.
KosugaM.; EnosawaS.; LiX-K.; SuzukiS.; MatsuoN.; YamadaM.; Roy-ChowdhuryJ.; KoiwaiO.; OkuyamaT.Strong, long-term transgene expression in rat liver using chicken β-actin promoter associated with cytomegalovirus immediate enhancer (CAG promoter).Cell Transplant.9: 675–680; 2000.
10.
KosugaM.; TakahashiS.; SasakiK.; EnosawaS.; LiX-K.; OkuyamaS.; FujinoM.; SuzukiS.; YamadaM.; MatsuoN.; SakuragawaN.; OkuyamaT.Phenotype correction in murine mucopolysaccharidosis type VII by transplantation of human amniotic epithelial cells after adenovirus-mediated gene transfer.Cell Transplant.9: 687–692; 2000.
11.
MiyamotoM.; MorimotoY.; NozawaY.; BalamuruganA. N.; XuB.; InoueK.Establishment of fluorescein diacetate and ethidium bromide (FDAEB) assay for quality assessment of isolated islets.Cell Transplant.9: 681–686; 2000.
12.
SatoY.; GrochowieckiT. R.; TakedaY.; DonoK.; IseK.; KanazawaY.; SaitoT.; AbeT.; GotohM.Grafting of mitomycin C-treated islet xenograft under the kidney capsule produces a clear bleb.Cell Transplant.9: 693–695; 2000.
13.
TaniguchiH.; KondoR.; SuzukiA.; ZhengY.; TakadaY.; FukunagaK.; SeinoK.; YuzawaK.; OtsukaM.; FukaoK.; NakauchiH.Clonogenic colony-forming ability of flow cytometrically isolated hepatic progenitor cells in the murine fetal liver.Cell Transplant.697–700; 2000.
14.
TeradaS.; MatsuuraK.; EnosawaS.; MikiM.; HoshikaA.; SuzukiS.; SakuragawaN.Inducing proliferation of human amniotic epithelial (HAE) cells for cell therapy.Cell Transplant.9: 701–704; 2000.